The Comprehensive Department of the Food and Drug Administration: Termination of protection of relevant Chinese medicine varieties early!

Medical Net, July 2nd, the Drug Administration of all provinces, autonomous regions, and municipalities directly under the Central Government, and the Xinjiang Construction Corps Drug Administration: According to the National Traditional Chinese Medicine Variety Protection Review Committee "Letter on Matters Concerning the Early Termination of Protection of Danggui Shaoyao Granules" (China Insurance Committee Letter [2021] No.
7), Hubei Huquan Pharmaceutical Co.
, Ltd.
applied for early termination of protection of Chinese medicine varieties of Danggui Shaoyao Granules
.
In accordance with the relevant provisions of the "Regulations on the Protection of Chinese Medicines" and the former State Food and Drug Administration "Notice on Printing and Distributing the Guiding Principles for the Protection of Chinese Medicines" (Guo Shi Yao Jian Zhu [2009] No.
57), the State Food and Drug Administration agreed to Hubei Huquan The application of the Pharmaceutical Co.
, Ltd.
and the opinions of the National Traditional Chinese Medicine Variety Protection Review Committee terminated early the protection of the Chinese medicine variety protection of Danggui Shaoyao Granules
.
The relevant matters are hereby notified as follows: 1.
Starting from the date of issuance of this notice, Hubei Huquan Pharmaceutical Co.
, Ltd.
Angelica Shaoyao Granules will no longer be managed according to the national protection of traditional Chinese medicine, and shall not be titled "national protection of traditional Chinese medicine"
.
2.
Request the Hubei Provincial Drug Administration to be responsible for withdrawing the approval documents of the national Chinese medicine protected varieties and the certificate of Chinese medicine protected varieties for the above-mentioned varieties
.
Comprehensive Department of the State Drug Administration June 28, 2021